We are concerned with the mechanisms whereby hydrophilic proteins synthesized in the cytoplasm are translocated across one or two membranes into different cellular organelles. On the basis of a model of the translocation process to be described elsewhere, we propose an explanation of previous findings that the in vitro translocation across the endoplasmic reticulum of secretory proteins of higher eukaryotic cells appears to be obligatorily co-translational (i.e., occurs only while the polypeptide chain is being synthesized on the ribosome). We suggest that in vitro the intrachain disulfide bonds of the polypeptide rapidly form after it is released from the ribosome; the three-dimensional conformation of the chain is thereby stabilized and cannot undergo the unfolding that is required for post-translational translocation. In accord with this proposal, we show that the secretory preprotein human preprolactin, after translation and release from the ribosome, can indeed undergo translocation across endoplasmic reticulum membranes in vitro if the medium is sufficiently reducing. Those polypeptides that, in the absence of reducing agents, can be post-translationally translocated in vitro across bacterial, mitochondrial, and other types of membranes may generally lack intrachain disulfide bonds.
Many of the membrane-bounded organelles in eukaryotic cells obtain most or all of their internal proteins from the cytoplasm. This generally involves the translocation of a wide range of large hydrophilic protein molecules from the cytoplasm across one or two membranes of the organelle. The mechanisms of such translocations have received a great deal of attention in the last decade, but they are still not well understood. In particular, while it would seem plausible that these mechanisms might be fundamentally the same in all such cases, the evidence until recently appeared to indicate that they were significantly different. Translocation of proteins across the endoplasmic reticulum (ER) of eukaryotic cells seemed to occur only while the polypeptide chain was being synthesized on ribosomes attached to the ER (i.e., translocation was obligatorily co-translational), whereas in other cases (bacterial, mitochondrial, peroxisomal, and chloroplast membranes) the polypeptide chain, after being completed and released from the ribosome, could generally be transported into the organelle (i.e., translocation could be post-translational). Of special significance have been in vitro studies demonstrating these differences, for example, between protein import into the ER of higher eukaryotic cells (co-translational) as compared to import into mitochondria (post-translational) (for reviews, see refs. 1 
and 2).
We have developed a general picture of how protein translocation might work (3) . This picture utilizes current ideas (4-7) about how the polypeptide chains of soluble proteins fold into their equilibrium tertiary structures. Briefly, our proposal involves the sequential translocation across the membrane of successive folded "subdomains" of the polypeptide chain until finally the entire chain is translocated. This process is initiated by the binding of the signal peptide, which is generally present at the amino terminus of the polypeptide chain, to a receptor in the appropriate membrane, which "seeds" (7) the formation of the first folded subdomain of the chain. As this subdomain is translocated across the membrane, the next stretch of the chain is folded into a second subdomain and is translocated. This energydependent process continues until the entire chain is transported across the membrane. For convenience, we refer to this mechanism as "subdomain translocation." In principle, this mechanism can function either co-translationally or post-translationally. In the latter case, the completed polypeptide chain that is released into the cytoplasm, still bearing its signal peptide, is presumably first rapidly folded into some tertiary conformation in the aqueous solution. If this polypeptide is subsequently to be transferred across a membrane by subdomain translocation, the tertiary conformation must be capable of being unfolded so that the initial and successive subdomains can be sequentially formed at the membrane and translocated. It occurred to us that if the released polypeptide chain, upon acquiring its tertiary conformation, also became rapidly cross-linked by intrachain cystine disulfide bridges, it would subsequently be incapable of unfolding to its subdomains; its post-translational translocation might thereby be blocked.
Let us pursue this suggestion further. The polypeptides that are translocated across the membrane ofthe ER in higher eukaryotic cells are mainly the precursors of secretory proteins, and it is known that most of these proteins contain multiple intrachain disulfide bridges. The cytoplasm of eukaryotic cells is highly reducing, because of its high concentration of glutathione (8) or all of the chain had been co-translationally translocated. In other words, under such circumstances co-translational but not post-translational translocation would be observed in in vitro experiments. These considerations can therefore explain the experimental findings that in vitro translocation across ER membranes appears to be obligatorily co-translational.
A prediction arising from these considerations is that in all those instances (e.g., with mitochondria) in which in vitro post-translational translocation has been observed experimentally, the proteins involved must lack stable disulfide bridges that would inhibit unfolding of the polypeptide chain. The data required to test this prediction are fragmentary and limited. However, we are not aware of any results that contradict this rather stringent prediction (see Discussion).
Another prediction is that, for a disulfide-containing secretory protein, the in vitro translocation of whose precursor polypeptide across ER membranes has previously been found to be obligatorily co-translational, the same experiments carried out in a suitable reducing milieu might allow post-translational translocation to occur. This prediction has been borne out by the experiments described in this paper. We have translated mRNA for human preprolactin (9) in a reticulocyte cell-free system, with or without added dog pancreas microsomes, and with or without added dithiothreitol. In the absence of dithiothreitol, translocation of the preprolactin across the microsomal membranes was obligatorily co-translational (9), but in the presence of sufficient dithiothreitol, post-translational translocation was observed.
MATERIALS AND METHODS
The procedure used to examine post-translational translocation was essentially that of Rothman and Lodish (10) In some experiments freshly prepared 200 mM or 500 mM dithiothreitol in H20 was added to this translation mixture to give final concentrations of 20 mM or 50 mM dithiothreitol, respectively. The mixtures were incubated at 37°C for 2 min. At this time, 20 mM 7-methylguanosine 5'-phosphate (m7GMP) in H20 was added (1:10, vol/vol) to stop further polypeptide chain initiation. After 3, 6, 10, 15, and 30 min at 37°C, 15-,ul aliquots were removed and added to 0.5 ,l of dog pancreas microsomal membranes (New England Nuclear). All mixtures were incubated for a total of 60 min and then brought to 4°C. The 15-,ul samples were then treated with ribonuclease A (1 ,g) (Sigma) for 10 min at 37°C with or without a prior treatment with trypsin as described below.
Control experiments were performed by adding the microsomal membranes at the start of translation, by omitting membranes entirely, or by omitting the mRNA.
To test for the inaccessibility of translocated polypeptide chains to protease digestion, to each 15-,ul sample was first added 3 ,ul of 10 mM CaCl2 in 20 mM Hepes buffer, pH 7.5.
After 10 min at 4°C, 9-pl portions were treated with 0.5 ,ug of tosylphenylalanyl chloromethyl ketone-treated trypsin (Worthington, Freehold, NJ) for 30 min at 4°C. Proteolysis was stopped by the addition of 10 ,ug of soybean trypsin inhibitor (Sigma), followed by another 10-min incubation at 4°C before the treatment with ribonuclease A.
For analysis by NaDodSO4/PAGE, all samples were diluted with 5 vol of sample buffer (0.03 M Tris HCl, pH 8 .0/5% NaDodSO4/4% 2-mercaptoethanol/16% glycerol, wt/vol/vol) containing 0.004% bromphenol blue and were boiled for 5 min. Equivalent amounts were then separated electrophoretically on 15% polyacrylamide gels (11) . After electrophoresis, the gels were fixed in 25% isopropyl alcohol/10% acetic acid (vol/vol) and treated with EN-3HANCE (New England Nuclear). The dried gels were then exposed to pre-flashed Kodak Blue Brand film for 48-96 hr at -70'C. The autoradiograms were scanned quantitatively with an LKB Ultroscan XL laser densitometer.
RESULTS
In the following experiments, m7GMP was added 2 min after the initiation of translation of the mRNA for preprolactin, to block further initiation of polypeptide chains without affecting the rate of elongation of chains that had already been initiated (10) . It is important for our purposes that the presence of 20 or 50 mM dithiothreitol during translation was found not to change the time course of incorporation of [35S]methionine into protein after addition of m7GMP (not shown). At 100 mM dithiothreitol, translation was markedly inhibited.
The translocation of preprolactin across ER membranes is accompanied by the cleavage of the signal peptide from the polypeptide chain (9) , resulting in a change in apparent molecular weight in PAGE experiments from 25,000 to 22,000. Polypeptide chains that are not translocated are not cleaved (9, 12) . These findings were confirmed (Fig. 1, lanes  A and B) . Translation in the absence of dog pancreas microsomal membranes resulted in intact preprolactin molecules (Fig, 1, lane A) . In the presence of membranes during translation, a large fraction of the preprolactin chains underwent signal peptide cleavage (Fig. 1, lane B) . When, after translation had occurred in the absence of dithiothreitol, the microsomes were added 3, 10, or 15 min later (Fig. 1 , lanes C, F, and I, respectively), no signal peptide cleavage was observed; these results are similar to those previously reported (9). However, when translation was carried out in the presence of 20 mM dithiothreitol and was followed by the addition of microsomes 3, 10, or even 15 min later (Fig. 1, lanes D, G, and J, respectively), a significant percentage of the preprolactin (36%, 34%, and 37%, respectively) underwent cleavage. At 50 mM dithiothreitol, the extent of cleavage at different times after addition of membranes was even more pronounced (Fig. 1, lanes E, H, and K, respectively, corresponding to 68%, 67%, and 51% cleavage, respectively). These results indicate that translocation, as detected by signal peptide cleavage, could occur post-translationally if sufficient dithiothreitol was present during translation and translocation.
A second criterion for translocation of a polypeptide across ER membranes is the protection conferred on the chain against digestion by added protease (13) . Thus, preprolactin translated in the absence of membranes was completely digested by trypsin (Fig. 2, lane B) , and when it was translated in the presence of membranes but the absence of dithiothreitol, a substantial fraction of the polypeptide after signal peptide cleavage was unaffected by trypsin (Fig. 2,  lanes C and D) . These results were as expected (13) . When, however, preprolactin was synthesized in the presence of 50 mM dithiothreitol and microsomal membranes were then added 3, 10, or 15 min later, essentially the same fraction of the prolactin was protected from trypsin ( Fig. 2, lanes F, H, and J, respectively) as was protected after co-translational translocation in the absence of dithiothreitol (Fig. 2, lane D) . In the absence of membrane integrity, the prolactin is fully digested by the trypsin treatment. generally been found to occur only co-translationally. This has been difficult to reconcile with comparable experiments carried out with bacterial and mitochondrial systems, in which in vitro post-translational translocation is often observed. The suggestion has therefore been made that translocation may occur by more than one basic mechanism, depending on the membrane system involved (2). However, our proposal that a general mechanism exists for all such translocations, involving the translocation of successive subdomains of the polypeptide chain across the membrane (3), suggested an explanation for these apparently conflicting results. During in vitro translocation experiments, which are normally carried out under nonreducing conditions, the intrachain cystine disulfide bridges characteristic -of the secretory protein might form after the completed polypeptide chain of the precursor was released from the ribosomes into the aqueous medium, and thus prevent the subsequent unfolding of the chain at the membrane that was required for successive subdomain translocations to occur. We have now shown that in media capable ofretaining the cysteine residues in the reduced state, post-translational translocation of the secretory protein precursor preprolactin can indeed occur, but not in the absence ofthe reducing agent (9) . Translocation across the ER membranes was demonstrated by cleavage of the signal peptide from the pre-protein (Fig. 1) , as well as by protection of the translocated protein against proteolysis ( Fig. 2; ref. 13 ). Prolactin is a protein of 190 amino acids that is 85% homologous to growth hormone (14) ; both proteins have four cysteine residues that normally form two disulfide bridges that link well-separated regions ofthe linear sequence (14) . Although it is clearly important to confirm these findings with other secretory proteins, in what follows we assume that these results will turn out to be generally valid. The thesis of this paper involves an important corollary, namely, that each polypeptide that can successfully be translocated post-translationally across the appropriate membrane in vitro under nonreducing conditions does not have disulfide bonds in its three-dimensional conformation that would inhibit the unfolding of that conformation and the formation of subdomains. We note, for example, that a yeast secretory protein, prepro-a factor, which has recently been shown to be post-translationally translocated across yeast ER membranes in vitro (15) (16) (17) , has no cysteine among its 165 amino acid residues (18) .
It appears that secretory proteins, lysosomal proteins, and the extracellular domains of integral membrane proteins of higher eukaryotic cells may be unusual in their relatively high cysteine content (up to 10 mol %) and particularly in the involvement of their cysteine residues in disulfide bond formation (8) . Proteins that are secreted by most bacteria, or that are imported into mitochondria or chloroplasts, generally have low cysteine contents (often less than 1 mol %), and even those with substantial numbers ofcysteine residues may generally not form disulfide bonds. A preliminary examination of an updated version of the NEWAT amino acid sequence data bank (19) (26) . as in Fig. 1 . Post-translational These considerations of in vitro protein translocation bear microsomal membranes is here on the mechanism by which the same process occurs in vivo location confers pn the polypep- (9) . However, co-translational translocation across the vith upward arrow in lane I) was ER membrane may generally be favored kinetically if the subdomain translocation mechanism is basically correct. A nascent polypeptide chain of a secretory protein, which is LATase) of chicken. Its polydirected to the ER membrane by a bound signal recognition Leine residues, and the x-ray particle (13), may then form and translocate its successive )) shows that none of these is subdomains continuously as the polypeptide chain is pro-(J. N. Jansonius, personal gressively synthesized. On the other hand, if the entire porting the probable absence preprotein is first completed and released and then becomes containing mitochondrial or folded into a three-dimensional conformation, it may have to Direct, and in view of space unfold partially to form sequential subdomains that can d here. Suffice it to say that translocate across the membrane. Post-translational transloformation to test the proposal cation across a membrane in vivo may therefore be substaninformation that contradicts tially slower than the corresponding co-translational process. the absence of disulfide bonds in any secreted bacterial protein, or in any imported mitochondrial or chloroplast protein, that has been shown to undergo post-translational translocation in vitro under the usual oxidizing conditions.
There are several unusual polypeptides whose in vitro translocation should provide interesting further tests of our proposals. Among the secretory proteins of higher eukaryotes, for example, several apolipoproteins have no cysteine (21, 22) . The corresponding pre-apolipoproteins, which must lack disulfide bonds, may be found to undergo post-translational translocation across dog pancreas microsomes in vitro under nonreducing conditions, unlike most other higher eukaryotic secretory proteins. Conversely, certain unusual bacterial secretory proteins resembling the eukaryotic serine proteases (23, 24) do contain disulfide bonds, and we predict that their preproteins will not be capable of post-translational translocation across bacterial membranes in vitro, except under reducing conditions. Similar considerations apply to the insertion of integral proteins into membranes. Whether such insertion in vitro appears to be obligatorily co-translational, as in the case of the G protein of vesicular stomatitis virus (9) , or can occur
